Local treatment for metastatic prostate cancer: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Local treatment for metastatic prostate cancer: A systematic review

Published:2018-03-23 Issue:5 Volume:25 Page:390-403
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Tilki Derya¹²,Pompe Raisa S¹³,Bandini Marco³⁴,Marchioni Michele³⁵,Kretschmer Alexander⁶,Tian Zhe³,Karakiewicz Pierre I³⁷,Evans Christopher P⁸

Affiliation:

1. Martini-Klinik Prostate Cancer Center; University Hospital Hamburg-Eppendorf; Hamburg Germany

2. Department of Urology; University Hospital Hamburg-Eppendorf; Hamburg Germany

3. Cancer Prognostics and Health Outcomes Unit; University of Montreal Health Center; Montreal Quebec Canada

4. Department of Urology and Division of Experimental Oncology; Urological Research Institute; IRCCS San Raffaele Scientific Institute; Milan Italy

5. Department of Urology; SS Annunziata Hospital; “G. D'Annunzio” University of Chieti; Chieti Italy

6. The Vancouver Prostate Center and Department of Urological Sciences; University of British Columbia; Vancouver British Columbia Canada

7. Department of Urology; University of Montreal Health Center; Montreal Quebec Canada

8. Department of Urology; Davis School of Medicine; University of California; Sacramento California USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13535/fullpdf

Reference20 articles.

1. Androgen deprivation therapy and secondary hormone therapy in the management of hormone-sensitive and castration-resistant prostate cancer;Saad;Urology,2015

2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration;Liberati;BMJ,2009

3. Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: a population-based, propensity score analysis;Antwi;Cancer Epidemiol.,2014

4. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study;Culp;Eur. Urol.,2014

5. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study;Fossati;Eur. Urol.,2015

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines;International Journal of Pharmaceutics;2024-10

2. Stellenwert der lokalen Therapien beim oligometastasierten, hormonsensitiven Prostatakarzinom;Die Urologie;2024-02-08

3. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

4. Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study;International Journal of Urology;2023-07-05

5. Cytoreductive radical prostatectomy versus no local treatment in patients with metastatic prostate cancer;Medwave;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3